Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.30 +0.96%   SPY: 166.94 +0.97%
Profile Portfolio  


  Track this Pro and follow their portfolio moves with tickerspy™ alerts  

RA Capital Management

  Performance       Similar Pro Portfolios       Community  
 
Today:
Week:
1-month:
All-time:
+1.9%
+7.4%
-0.6%
+45.6%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
+1.0%
+5.4%
-8.0%
+24.7%
 

Data since: Jan-1-2008
Current Portfolio: Q3 2012


     
FIC Capital +0.7%
Raging Capital ... +1.4%
Marxe W. Austin... +2.0%
     
39 members Tracking
Share this Pro on Facebook
Share this Pro on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
   
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Q3 2012 View as: Alerts Holdings Detail
 ACAD $13.27 +0.26 +2.00% 3,774,856 76% $974.7M - 925% -5% +437.2% $11.2M | 4.4M shares - decrease of 666.2K shares
 ACHN $7.77 +0.21 +2.78% 823,358 77% $750.2M - 43% -32% -27.2% $21.9M | 2.1M shares - decrease of 1.1M shares
 ANAC $6.09 -0.01 -0.16% 930,678 144% $246.6M - 103% -26% -6.6% $16.7M | 2.5M shares - increase of 138.6K shares
 ARTC $34.65 +0.20 +0.58% 160,474 144% $976.7M - 42% -6% +6.0% $14.2M | 439.2K shares - decrease of 123.2K shares
 CNDO $9.90 -0.17 -1.69% 322,120 77% $259.0M - 148% -22% +74.0% $9.2M | 1.8M shares - increase of 1.9K shares
 DSCI $14.29 -0.06 -0.42% 35,765 68% $236.1M - 62% -4% +33.3% $13.0M | 1.3M shares - No Change
 DYAX $2.54 +0.05 +2.01% 420,622 44% $253.9M - 66% -44% -4.5% $22.2M | 8.5M shares - No Change
 INSM $10.90 +0.34 +3.22% 440,262 157% $344.1M - 305% -3% +134.7% $11.2M | 2.5M shares - New Holding
 NVAX $2.01 -0.05 -2.43% 1,192,194 67% $304.0M - 79% -27% -15.9% $28.5M | 13.2M shares - No Change
 OGXI $10.50 +0.08 +0.77% 85,257 108% $154.0M - 15% -30% -26.9% $7.4M | 523.4K shares - decrease of 62.5K shares
 SGMO $8.43 +0.17 +2.06% 611,291 71% $451.3M - 109% -25% +36.6% $13.0M | 2.1M shares - decrease of 33.2K shares
 SNMX $2.09 -0.01 -0.48% 21,990 13% $84.9M - 37% -29% +9.4% $5.2M | 2.8M shares - increase of 817.6K shares
 SNSS $5.46 +0.05 +0.92% 216,330 69% $281.7M - 137% -20% -3.9% $14.6M | 2.6M shares - New Holding
 VNDA $6.58 +1.08 +19.64% 3,379,397 1153% $186.5M - 125% 18% +61.7% $9.5M | 2.4M shares - decrease of 245.1K shares
 VSTM $9.19 -0.25 -2.65% 53,340 260% $189.6M - 47% -23% -2.6% $5.2M | 557.8K shares - decrease of 47.8K shares
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss RA Capital Management's portfolio
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
XOM  LLY  BP  MUR  BPL  KMP  MNKD  AZN  MT  ACAD  GHDX  X  DK  WES  KNOW  NFO  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 18, 03:54PM from (www.benzinga.com)
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Derma Sciences Reports First Quarter 2013 Financial Results
DSCI  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (www.businesswire.com)
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
ACAD  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 15, 08:00AM from (www.businesswire.com)
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
ACAD  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 04:01PM from (www.businesswire.com)
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Derma Sciences Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S.
DSCI  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 07:30AM from (www.businesswire.com)
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Jack Green Joins Verastem as Chief Financial Officer
VSTM  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 07:00AM from (www.businesswire.com)
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dyax Announces $30 Million Offering
DYAX  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 13, 07:15AM from (www.businesswire.com)
Dyax Corp. (NASDAQ: DYAX) announced today that it has priced a registered direct offering with RA Capital Management, Venrock,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sunesis to Present at Upcoming Investor Conferences
SNSS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 03:43PM from (globenewswire.com)
SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing
NVAX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:13AM from (globenewswire.com)

ROCKVILLE, Md., May 10, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has completed  more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results
ANAC  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:01PM from (www.businesswire.com)
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the first quarter ended March 31, 2013. “It  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights
SNSS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 07:13AM from (globenewswire.com)
SOUTH SAN FRANCISCO, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vanda Pharmaceuticals Reports First Quarter 2013 Results
VNDA  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 09, 06:55AM

WASHINGTON, May 9, 2013 /PRNewswire/ -- Vanda Pharmaceuticals  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sangamo BioSciences Reports First Quarter 2013 Financial Results
SGMO  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 08, 04:02PM

RICHMOND, Calif., May 8, 2013 /PRNewswire/ -- Sangamo BioSciences,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013
CNDO  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 07:43AM from (globenewswire.com)
BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results
ACAD  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ArthroCare Reports First Quarter 2013 Financial Results
ARTC  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com)
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast
ANAC  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com)
Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the first quarter ended March 31, 2013, on Thursday,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
CNDO  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 07, 08:43AM from (globenewswire.com)
BURLINGTON, Mass., May 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Derma Sciences to Hold First Quarter Financial Results Conference Call on May 16th
DSCI  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 07:30AM from (www.businesswire.com)
Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Insmed Reports First Quarter Financial Results
INSM  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 07, 07:30AM from (www2.marketwire.com)
Insmed Incorporated (NASDAQ: INSM), ("Insmed" or the "Company"), a biopharmaceutical company focused  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 41



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.